Does BOSUTINIB Cause Haematotoxicity? 32 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 32 reports of Haematotoxicity have been filed in association with BOSUTINIB (BOSULIF). This represents 0.4% of all adverse event reports for BOSUTINIB.
32
Reports of Haematotoxicity with BOSUTINIB
0.4%
of all BOSUTINIB reports
3
Deaths
11
Hospitalizations
How Dangerous Is Haematotoxicity From BOSUTINIB?
Of the 32 reports, 3 (9.4%) resulted in death, 11 (34.4%) required hospitalization, and 4 (12.5%) were considered life-threatening.
Is Haematotoxicity Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOSUTINIB. However, 32 reports have been filed with the FAERS database.
What Other Side Effects Does BOSUTINIB Cause?
Diarrhoea (1,820)
Nausea (886)
Fatigue (626)
Vomiting (469)
Death (465)
Rash (426)
Pleural effusion (398)
Neoplasm progression (376)
Dyspnoea (319)
Headache (283)
What Other Drugs Cause Haematotoxicity?
CYCLOPHOSPHAMIDE (1,410)
DOXORUBICIN (1,180)
VINCRISTINE (1,038)
RITUXIMAB (812)
CARBOPLATIN (803)
METHOTREXATE (799)
PREDNISONE (730)
CYTARABINE (701)
ETOPOSIDE (677)
CISPLATIN (668)
Which BOSUTINIB Alternatives Have Lower Haematotoxicity Risk?
BOSUTINIB vs BOTOX
BOSUTINIB vs BOTOX COSMETIC
BOSUTINIB vs BOTULINUM TOXIN NOS
BOSUTINIB vs BOTULINUM TOXIN TYPE A
BOSUTINIB vs BREMELANOTIDE